Skip To Main Content
Xiaofeng Lan on Muck Rack

Xiaofeng Lan

As seen in: Nature, Wiley Online Library, Dove Medical Press
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Xiaofeng Lan’s profile

Articles by Xiaofeng Lan

Identifying neurophenotypes of major depressive disorder through normative model of regional homogeneity

|
By Zhanjie Luo, Weicheng Li, Yubing Xu, Junhao Shen, Chengyu Wang, Xiaofeng Lan, Guanxi Liu, Zhaoyi Hou, Xiangdong Sun, Hanna Lu, Yuping Ning, Zhanhui Luo, Siming Mai, Muqin Zhang
| Nature Verified
Abstract Major depressive disorder (MDD) is a highly heterogeneous mental illness, marked by clinical variability and distinct neuropathological mechanisms. This study sought to enhance diagnostic precision for MDD by identifying neurophenotypes using a normative model of regional homogeneity (ReHo), offering new avenues for precision medicine.
Open in Who Shared Issue with article?

The late-time cardiac safety of long-term trastuzumab-based treatment | BCTT

|
By Xuelian Chen, Xiaofeng Lan, li xiao, Lin Song
| Dove Medical Press
Back to Journals » Breast Cancer: Targets and Therapy » Volume 17 Authors Chen X, Lan X, Xiao L, Song L, Huang J , Xie X, Chen L, Bai X, Du C Received 25 July 2025 Accepted for publication 12 November 2025 Published 25 November 2025 Volume 2025:17 Pages 1101—1110 DOI https://doi.org/10.2147/BCTT.S553442 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Professor Robert Clarke Xuelian Chen,* Xiaofeng Lan,* Li...
Open in Who Shared Issue with article?

The Restoration of Energy Pathways Indicates the Efficacy of Ketamine Treatment in Depression: A Metabolomic Analysis

|
By Zerui You, Chengyu Wang, Haiying Liu, Xiaofeng Lan
| Wiley Online Library Verified
1 Introduction Ketamine has expeditious and robust antidepressant effects, triggering significant theoretical and clinical progress in the treatment of major depressive disorder (MDD) [1]. Ketamine has been used as a rapid-acting antidepressant for depression patients, while simultaneously diminishing the intensity of suicidal ideation [2-5]. Previous studies have shown that the antidepressant and anti-suicidal effects of six repeated ketamine injections can persist for more than two weeks [6, 7].
Open in Who Shared Issue with article?
Show More